The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
* This Week in the Journal
 August 14, 2008
 Audio Icon Audio Summary
*
Correspondence
* Multiple Biomarkers and Cardiovascular Risk
* Sudden Cardiac Arrest Associated with Early Repolarization
* Tumor Angiogenesis
* Pursuit of an Expanded Physician Supply
* Glucagon-like Peptide 1–Receptor Scans to Localize Occult Insulinomas
* Anti–Glomerular Basement Membrane Disease after Alemtuzumab
*
Book Reviews
* Diseases of the Pancreas: Current Surgical Therapy
* Principles and Practice of Gastrointestinal Oncology
* Prostate Cancer: Signaling Networks, Genetics, and New Treatment Strategies
*
Continuing Medical Examination
* Effect of PCI on Quality of Life in Patients with Stable Coronary Disease
* Naltrexone for the Management of Alcohol Dependence
* Case 25-2008: A 43-Year-Old Man with Fatigue and Lesions in the Pituitary and Cerebellum
Original Articles
Effect of PCI on Quality of Life in Patients with Stable Coronary Disease

In the COURAGE trial, percutaneous coronary intervention (PCI), added to optimal medical therapy, did not reduce the subsequent rate of death or myocardial infarction among patients with chronic coronary disease. A quality-of-life analysis showed that measures of health status improved significantly with either strategy, but patients in the PCI group had greater initial improvements.

Related Editorial


Original Articles
Bivalirudin vs. Unfractionated Heparin during PCI

Bivalirudin is a new direct thrombin inhibitor. In patients undergoing PCI for stable coronary disease, bivalirudin and unfractionated heparin resulted in similar overall outcomes, but there was less major bleeding with bivalirudin.


Original Articles
Effects of Tibolone in Older Postmenopausal Women

In this trial, tibolone, which has estrogenic, progestogenic, and androgenic effects, was compared with placebo in women between 60 and 85 who had osteoporosis or a vertebral fracture. Tibolone was associated with a reduced risk of fracture, breast cancer, and possibly colon cancer. But the drug was associated with an increased risk of stroke and therefore should generally be avoided in elderly women and in women with risk factors for stroke.

Related Editorial


Original Articles
Brief Report: Pediatric Heart Transplantation after Declaration of Cardiocirculatory Death

This report describes transplantation of hearts from three infant donors (mean age at donation, 3.7 days) who had died from cardiocirculatory causes. The recipients (mean age, 2.2 months) all survived to 6 months with excellent left ventricular function. This approach to transplantation has been controversial but offers the prospect of expanding the donor pool.

Related Editorial

Related Perspective

Related Perspective

Related Perspective


Clinical Therapeutics
Naltrexone for the Management of Alcohol Dependence

A 44-year-old businessman presents with clinical evidence of alcohol dependence and acknowledges excessive drinking. The use of naltrexone is recommended. Naltrexone is an opioid-blocking agent that inhibits reward signaling in the brain and reduces alcohol craving. Hepatotoxicity has been reported with naltrexone. This drug should not be used in patients who are physically dependent on opiates.


Review Article
Molecular Origins of Cancer: Chromosomal Abnormalities in Cancer

This review gives an account of chromosomal aberrations in cancer cells. Such abnormalities have typically been associated with hematologic cancers, but recent work has shown a variety of chromosomal changes in solid tumors, including prostate cancer and non–small-cell lung cancer. The authors point out that some of the chromosomal abnormalities have revealed targets for cancer treatment, and others have clinical application in the diagnosis of certain types of neoplasms and in the formulation of a prognosis.


Case Records of the Massachusetts General Hospital
A Man with Fatigue and Lesions in the Pituitary and Cerebellum

A 43-year-old man was seen in the rheumatology clinic because of fatigue and lesions in the pituitary and cerebellum. Diabetes insipidus, hypogonadism, and hypothyroidism had developed beginning 9 years earlier, and lesions had been detected in the region of the pituitary stalk and in the cerebellum. He was treated with glucocorticoids for suspected neurosarcoidosis, but fatigue, ataxia, and neurologic symptoms worsened. Computed tomography of the chest and abdomen disclosed abnormal soft tissue surrounding the aorta, renal arteries, and kidneys. A diagnostic procedure was performed.


Clinical Implications of Basic Research
Harnessing the Power of Bacteria to Protect the Gut

A recombinant version of the bacterial protein flagellin protects the mouse gut and bone marrow against the effects of irradiation.


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.